Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005201-19-000072
Filing Date
2019-05-09
Accepted
2019-05-09 09:22:53
Documents
94
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a3312019-form10xq.htm 10-Q 1299582
2 EXHIBIT 10.1 exhibit101-amendedandresta.htm EX-10.1 47688
3 EXHIBIT 10.2 exhibit102.htm EX-10.2 8974
4 EXHIBIT 31.1 exhibit311-1q2019.htm EX-31.1 12991
5 EXHIBIT 31.2 exhibit312-1q2019.htm EX-31.2 12859
6 EXHIBIT 32.1 exhibit321-1q2019.htm EX-32.1 6857
7 EXHIBIT 32.2 exhibit322-1q2019.htm EX-32.2 6901
  Complete submission text file 0001005201-19-000072.txt   7762067

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT asrt-20190331.xml EX-101.INS 1676959
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20190331.xsd EX-101.SCH 65981
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20190331_cal.xml EX-101.CAL 99103
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20190331_def.xml EX-101.DEF 314252
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20190331_lab.xml EX-101.LAB 761886
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20190331_pre.xml EX-101.PRE 468619
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

EIN.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13111 | Film No.: 19809050
SIC: 2834 Pharmaceutical Preparations